Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy-Reference-Cited by-同舟云学术

Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy

Published:2020-05-23 Issue:2 Volume:35 Page:417-432
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Cartel Maëlle,Mouchel Pierre-Luc,Gotanègre Mathilde,David Laure,Bertoli Sarah,Mansat-De Mas Véronique,Besson Arnaud^ORCID,Sarry Jean-Emmanuel,Manenti Stéphane,Didier Christine^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-0878-x.pdf

Reference42 articles.

1. Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373:1136–52.

2. Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209–21.

3. Yang M, Zhao J, Liu T, Yang X, Wei H, Xu W, et al. Use of FLT3 inhibitors in acute myeloid leukemia remission induction or salvage therapy: systematic review and meta-analysis. Cancer Manag Res. 2018;10:2635–52.

4. DiNardo CD, Stein EM, de Botton S, Roboz GJ, Altman JK, Mims AS, et al. Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML. N Engl J Med. 2018;378:2386–98.

5. Zhou J, Chng WJ. Resistance to FLT3 inhibitors in acute myeloid leukemia: molecular mechanisms and resensitizing strategies. World J Clin Oncol. 2018;9:90–7.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of potential inhibitors for drug resistance in acute lymphoblastic leukemia through differentially expressed gene analysis and in silico screening;Analytical Biochemistry;2024-11

2. Deubiquitinases at the interplay between hematopoietic stem cell aging and myelodysplastic transformation;FEBS Letters;2024-08-06

3. Ubiquitin-specific proteases (USPs) in leukemia: a systematic review;BMC Cancer;2024-07-25

4. Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity;iScience;2024-05

5. USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia;Oncogene;2023-12-16